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75% in the no-treatment arm (p=0.04). (2) Secondary end points: Death st one week was 
23% in the L-NMMA arm vs. 75% in the no-treatment arm (p=0.01). Unaugrnented mean 
arterial blood pressure (MAP) at 24 hours was 80±17 mmHg in the L-NMMA arm vs. 
66±13 mmHg in the no-treatment arm (p=0.04). MAP increased by 20±17 mmHg vs 
2.5±10 mmHg respectively (p=0.005). Udne output at 24 hours was 223±88 cc/hour in 
the L-NMMA arm vs 119±93 cc/hour in the no-treatment arm (p=0.Ol). Udne output 
increased by 141±81 cc/hour in the L-NMMA arm vs -11±93 cc/hour in the no treatment 
arm (p=0.001). Time on IABP was 59±58 hours in the L-NMMA arm vs. 90±56 hours in 
the no treatment arm (p=0.15). "[]me on mechanical ventilation was 73±51 hours and 
121 ±53 hours respectively (p=0.03). 
Conclusion: From these preliminary results it seems that L-NMMA is beneficial in the 
treatment of patients in refractory cardiogenic shock. 
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862-6 E lec t rocard iograph ic  Lef t  Vent r i cu la r  Hyper t rophy  Is 
Associated With Mortality and Left  Vent r i cu la r  Rupture 
in Patients With Acute Myocardial Infarction 
David S. Marks, Surendra B. Gudapati, James F. Kleczka, Sabina A. Murphy, 
Christopher P. Cannon, Eugene Braunwald, C. M, Gibson, Medical College of Wisconsin, 
Milwaukee, Wisconsin, Harvard Medical School, Boston, Massachusetts. 
Background: Left ventricular hypertrophy (LVH) is a potent predictor of cardiovascular 
events, particularly in the presence of coronary artery disease. The impact of LVH in 
patients with acute myocardial infarction is incompletely understood. 
Methods: The data sets of TIMI lOB and TIM114 were pooled. Electrocardiograms were 
classified as LVH present (n=191), LVH absent (n=1,250), or uninterpretable (n=91). Mul- 
tivariate analysis was performed to examine 30 day mortality, TIMI flow, and cause of 
death. 
Results: Patients with electrocardiographic LVH compared to LVH absent were older 
(60.5 vs 58.3 years; p=0.01), black race (13.4 vs 4.1%; p<O.O01), and experienced an 
anterior MI (42.2 vs 33.7%). Death (6.25 vs 3.1%; p=0.029) and the composite death/MI/ 
failure/shock (12.5 vs 8.1%; p=0.04) were increased in the LVH group, Angiogrephic 
characteristics including TIMI flow did not differ between groups. The LVH group died fre- 
quently from ventricular rupture compared to LVH absent (33.3 vs 7.8%; p=0.04). 
Patients with uninterpretable lectrocardiograms had the highest mortality (9.9%) with no 
increase in ventricular upture (11.1%). 
Conclusions: In patients treated with lytic reperfusion therapy, the presence of electro. 
cardiographic LVH portends a significantly worse outcome, independent of coronary 
blood flow. Moreover, these patients died more frequently from ventricular upture com- 
pared to patients without LVH. Further investigation is required to determine the mecha- 
nism of increased mortality and the increased incidence of ventdcular rupture. 
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1192-31 An Intramyocardial Imp lant  Sys tem Su i tab le  for 
Susta ined-Re lease  Del ivery  to Ischemic Myocardium 
Takafumi Ueno. Keith A. Robinson, Jianhua Cui, Jennifer J. Fitzgerald, David M. 
Hoganson, John E. Nash, Nicolas Chronce, Atlanta Cardiovascular Research Institute, 
Norcross, Georgia, Kensey Nash Coporation, Exton, Pennsylvania. 
Background: Current techniques for local treatment of diseased myocardium with drugs 
or genes do not allow sustained retease. A bioabsorbable polymer implant system was 
tested for local tissue reaction and potential utility to deliver therapeutic agents. Meth- 
ods: Normal juvenile pigs (n=3); and juvenile (n=13) and adult Yucatan (n=12) pigs with 
chronic myocardial ischemia induced by coronary amereid constriction received braided 
polylactide/polyglycotide implants (average 12 implants) or sham therapy by direct injec- 
tion implantation into the left ventdcular free wall via thoracotomy. Responses to implant 
and sham injections were evaluated by dobutamine stress echocerdiography (DSE), cor- 
onary angiography, micrcephere-based blood flow measurement, histology, and histo- 
morphometry. Results: Implantation was readily achieved without significant bleeding 
using the prototype system. Absorption of implants was nearly complete by 3 rod, via 
histiolymphocytic and fibrotic reaction accompanied by local neovascularization. In the 
amereid study, 3 pigs died after amereid placement, 2 after baseline DSE, and 2 after 
intramyocardial injection procedures. There were no differences between sham-injected 
or implanted pigs (juvenile at 1 mo, or Yucatan at 3 rod) in regional wall motion scores on 
DSE, % stenosis or collateral scores by angiography, or in myocardial blood flow at rest 
or cardiac pacing. However, pigs receiving implants in the ischemic zone had increased 
capillary density compared to those receiving sham injection in epicardial (597+103 vs 
460+167/mm 2, P=0.05) and tendency in endocardial (675+183 vs 489+210/mm 2,
P=0.06) regions. Curiously, this effect also involved the adjacent non-ischemic non- 
injected myccardium (586+138 vs 403+164/mm 2, P=0.02 in epicardium; 617+188 vs 
427+222/mm 2, trend at P=O.08 for endocardium). Conclusions: A novel intramyocardial 
absorbable implant does not impair cardiac function after implant in chronically ischemic 
tissue, and is associated with increased angiogenesis. This system may be useful for 
localized sustained-release delivery of conventional drugs or gene-based molecular ther- 
apies in treatment of chronic myocardial ischemia. 
ABSTRACTS - Myocardial Infarction and Ischemia 331A 
1192-32 Increas ing  Left  Vent r i cu la r  Spher ic i ty  Is Associated 
With Decreased  Surv iva l  Even  in Pat ients  With TIMI-3 
Flow or Inferior Infarction 
Selwvn P. Wono, John K. French, Wanzhen Gad, Harvey D. White, Green Lane Hospital, 
Auckland, NewZealand. 
Background: Following acute myocardial infarction (MI), left ventdcu~ar (LV) function and 
volumes are closely associated with late survival, though there is little data on the rela- 
tionship between LV sphericity and late survival Method & Results: To examine the asso- 
ciation between late survival and LV sphericity, assessed on biplane contrast 
ventriculogrephy at 3 weeks, we studied 767 patients presenting with electrocardio- 
graphic ST-segment elevation within 4 hours of symptom-onset who were enrolled in 3 
trials of thrombolytic and adjunctive therapies. When both ventricular volumes and 
regional wall motion were normal, median biplane LV sphericity index was 0.56 (inter- 
quartile range 0.51-0.60), determined as the average ratio of the short to long axes in the 
right and left anterior oblique projections. Decreased survival was associated with 
increasing LV sphericity even in patients with TIMI 3 flow or inferior infarction (Fig). inde- 
pendent multivariate predictors of decreased 10 year survival were lower ejection fraction 
(P=O.002), decreased treadmill exercise duration (P=0.04), increasing sphericity index 
(P=0.032), increased age (P=0.043), and increased end-systolic volume index (P=0.047) 
but not TIMI flow grade or infarct-related artery. Conclusion. The simple biplane LV sphe- 
ricify index of the ratios of the minor to major axis predicts late survival in patients with 
TIM1 3 flow or inferior MI. 
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1192-33 Thrombo ly t i c  F ibr in  Spec i f i c i ty  In f luences  Act ivated  
Partial Thromboplastln Time Prolongation 
James p, Tsikouds, Kenneth C. Jackson, II, Craig D. Cox, Gary E. Msyerrese, Jose A. 
Diaz, Chades F. Seifert, Texas Tech University Health Science Center, Lubbock, Texas. 
Despite limited clinical trial evidence, current guidelines suggest the same unfractionated 
hepadn (UFH) dosing for all fibrin specific thrombolytic agents used for acute myocardial 
infarction (AMI). Since excessive aPTT prolongation correlates with bleeding and mortal- 
ity, clarifying the effects of various fibrin specific agents on the aP'l-r is needed. Alteplase 
(rt-PA) is slightly more fibrin specific than reteplase (r-PA), and tenecteplase (TNK) is 
exceedingly more fibrin specific than rt-PA and r-PA. Methods: We treated blood samples 
from healthy volunteers (n=12) with equipotent concentrations of rt-PA (4 mcg/ml), r-PA 
(4.2 mcg/rnl), or TNK (8.6 mcg/ml), with and without UFH (0.3 U/ml). Each treatment 
group samples - rt.PA alone, r-PA alone, TNK alone, UFH, UFH + rt.PA, UFH + r-PA, 
UFH + TNK - were incubated at simulated body temperature, with aPTT and fibrinogen 
measured after 4 hours. Data were analyzed using repeated measures ANOVA with 
Bonferreni t-test and Pearson correlation. Mean aPTT values for rt-PA alone and r-PA 
alone were significantly prolonged compared to TNK alone, which were in the normal 
range for 11 of 12 patients (85 vs. 62 vs. 32 secs, respectively, p=0.001 for both), rt-PA 
alone prolonged the aPTT to a greater extent than r-PA alone (p<0.02). Combined with 
UFH, rt-PA end r-PA significantly increased the aPTT vs. UFH alone (234 and 228 vs. 
187 secs, p<0.02 for both). Interestingly, UFH + TNK significantly reduced the aP'l-r vs. 
UFH alone (137 vs. 187 secs, respectively, p<0.001). This finding was consistent for all 
12 patients. A significant correlation existed between decreasing fibrinogen and increas- 
ing aPT1" for all treatments (p<0.05), except TNK alone, which minimally reduced fibrino- 
gen vs. UFH alone. This relative comparison shows that an agent with maximal fibrin 
specificity (TNK) is unlikely to prolong the aP'l-r, while less fibrin specific agents have a 
greater propensity to prolong the aPTT with and without UFH. Also, TNK attenuates the 
